The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Ketone Bodies as a Therapeutic for Alzheimer's Disease
Open accessAbstract
An early feature of Alzheimer's disease (AD) is region-specific declines in brain glucose metabolism. Unlike other tissues in the body, the brain does not efficiently metabolize fats; hence the adult human brain relies almost exclusively on glucose as an energy substrate. Therefore, inhibition of glucose metabolism can have profound effects on brain function. The hypometabolism seen in AD has recently attracted attention as a possible target for intervention in the disease process. One promising approach is to supplement the normal glucose supply of the brain with ketone bodies (KB), which include acetoacetate, beta-hydroxybutyrate, and acetone. KB are normally produced from fat stores when glucose supplies are limited, such as during prolonged fasting. KB have been induced both by direct infusion and by the administration of a high-fat, low-carbohydrate, low-protein, ketogenic diets. Both approaches have demonstrated efficacy in animal models of neurodegenerative disorders and in human clinical trials, including AD trials. Much of the benefit of KB can be attributed to their ability to increase mitochondrial efficiency and supplement the brain's normal reliance on glucose. Research into the therapeutic potential of KB and ketosis represents a promising new area of AD research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Brain's Default Network: Anatomy, Function, and Relevance to Disease
Buckner, R. L., Andrews‐Hanna, J. R., & Schacter, D. L. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1440.011 · Cited by 9,761
Buckner, R. L., Snyder, A. Z., Shannon, B. J., LaRossa, G., Sachs, R., Fotenos, A. F., Sheline, Y. I., Klunk, W. E., Mathis, C. A., Morris, J. C., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2177-05.2005 · Cited by 2,140 · cited 13×
“In a series of experiments, Reiman et al. 15 examined the onset of hypometabolism in nondemented subjects at risk for AD.”
BackgroundInfluentialBrain Metabolism during Fasting*
Owen, O. E., Morgan, A. P., Kemp, H. G., Sullivan, J. M., Herrera, M. G., & Cahill, G. F. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105650 · Cited by 1,646
Raichle, M. E., & Mintun, M. A. (2006) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.29.051605.112819 · Cited by 1,630
Reiman, E. M., Caselli, R. J., Yun, L. S., Chen, K., Bandy, D., Minoshima, S., Thibodeau, S. N., & Osborne, D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603213341202 · Cited by 1,366
The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation
Halestrap, A. P., & Price, N. T. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3430281 · Cited by 1,348
Medium-chain triglycerides: an update
Bach, A., & Babayan, V. (1982) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/36.5.950 · Cited by 1,151
Physiological roles of ketone bodies as substrates and signals in mammalian tissues.
Robinson, A. M., & Williamson, D. H. (1980) · Physiological Reviews · doi:10.1152/physrev.1980.60.1.143 · Cited by 1,012
Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia
Reiman, E. M., Chen, K., Alexander, G. E., Caselli, R. J., Bandy, D., Osborne, D., Saunders, A. M., & Hardy, J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2635903100 · Cited by 977
Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer’s disease
Small, G. W., Ercoli, L. M., Silverman, D. H. S., Huang, S.-C., Komo, S., Bookheimer, S. Y., Lavretsky, H., Miller, K., Siddarth, P., Rasgon, N. L., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.090106797 · Cited by 790
Circulation and Energy Metabolism of the Brain
Clarke, D. D., & Sokoloff, L. (1999) · Cited by 732
Risner, M. E., Saunders, A. M., Altman, J. F. B., Ormandy, G. C., Craft, S., Foley, I. M., Zvartau-Hind, M. E., Hosford, D. A., Roses, A. D., & for the Rosiglitazone in Alzheimer's Disease Study Group (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500369 · Cited by 686
Moechars, D., Dewachter, I., Lorent, K., Reversé, D., Baekelandt, V., Naidu, A., Tesseur, I., Spittaels, K., Haute, C. V. D., Checler, F., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6483 · Cited by 668
(d)-β-Hydroxybutyrate Inhibits Adipocyte Lipolysis via the Nicotinic Acid Receptor PUMA-G
Taggart, A. K. P., Kero, J., Gan, X., Cai, T.-Q., Cheng, K., Ippolito, M., Ren, N., Kaplan, R., Wu, K., Wu, T.-J., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500213200 · Cited by 650
Ho, L., Qin, W., Pompl, P. N., Xiang, Z., Wang, J., Zhao, Z., Peng, Y., Cambareri, G., Rocher, A., Mobbs, C. V., et al. (2004) · The FASEB Journal · doi:10.1096/fj.03-0978fje · Cited by 630
Reger, M. A., Watson, G. S., Frey, W. H., Baker, L. D., Cholerton, B., Keeling, M. L., Belongia, D. A., Fishel, M. A., Plymate, S. R., Schellenberg, G. D., et al. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.03.016 · Cited by 621
Energetic basis of brain activity: implications for neuroimaging
Shulman, R. G., Rothman, D. L., Behar, K. L., & Hyder, F. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.06.005 · Cited by 590
Liang, W. S., Reiman, E. M., Valla, J., Dunckley, T., Beach, T. G., Grover, A., Niedzielko, T. L., Schneider, L. E., Mastroeni, D., Caselli, R., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709259105 · Cited by 585 · cited 1×
“Other studies have indicated that the declines in energy metabolism may be directly due to low expression of energy metabolism genes in affected areas of the brain, such as neurons of the posterior cingulate.(23)”
BackgroundCraft, S., Peskind, E., Schwartz, M. W., Schellenberg, G. D., Raskind, M., & Porte, D. (1998) · Neurology · doi:10.1212/wnl.50.1.164 · Cited by 560
d -β-Hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease
Kashiwaya, Y., Takeshima, T., Mori, N., Nakashima, K., Clarke, K., & Veech, R. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.10.5440 · Cited by 535
Effects of β-hydroxybutyrate on cognition in memory-impaired adults
Reger, M. A., Henderson, S. T., Hale, C., Cholerton, B., Baker, L. D., Watson, G. S., Hyde, K., Chapman, D., & Craft, S. (2004) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00087-3 · Cited by 508
Self-citationD-β-Hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease
Tieu, K., Perier, C., Caspersen, C., Teismann, P., Wu, D.-C., Yan, S.-D., Naini, A., Vila, M., Jackson-Lewis, V., Ramasamy, R., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318797 · Cited by 497
Maalouf, M., Sullivan, P. G., Davis, L., Kim, D. Y., & Rho, J. M. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.11.065 · Cited by 477
Apolipoprotein E and Alzheimer's disease
Strittmatter, W. J., & Roses, A. D. (1996) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.19.030196.000413 · Cited by 477
Autophagy and neurodegeneration: when the cleaning crew goes on strike
Martinez-Vicente, M., & Cuervo, A. M. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70076-5 · Cited by 474
Insulin, ketone bodies, and mitochondrial energy transduction
Sato, K., Kashiwaya, Y., Keon, C. A., Tsuchiya, N., King, M. T., Radda, G. K., Chance, B., Clarke, K., & Veech, R. L. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.8.7768357 · Cited by 454
Neuroprotective and disease-modifying effects of the ketogenic diet
Gasior, M., Rogawski, M. A., & Hartman, A. L. (2006) · Behavioural Pharmacology · doi:10.1097/00008877-200609000-00009 · Cited by 445
Ketone Bodies, Potential Therapeutic Uses
Veech, R. L., Chance, B., Kashiwaya, Y., Lardy, H. A., & Cahill, G. F. (2001) · IUBMB Life · doi:10.1080/152165401753311780 · Cited by 429
The ketogenic diet increases mitochondrial uncoupling protein levels and activity
Sullivan, P. G., Rippy, N. A., Dorenbos, K., Concepcion, R. C., Agarwal, A. K., & Rho, J. M. (2004) · Annals of Neurology · doi:10.1002/ana.20062 · Cited by 411
GLUT-1 deficiency syndrome caused by haploinsufficiency of the blood-brain barrier hexose carrier
Seidner, G., Alvarez, M. G., Yeh, J.-I., O'Driscoll, K. R., Klepper, J., Stump, T. S., Wang, D., Spinner, N. B., Birnbaum, M. J., & De Vivo, D. C. (1998) · Nature Genetics · doi:10.1038/ng0298-188 · Cited by 386
Gabuzda, D., Busciglio, J., Chen, L. B., Matsudaira, P., & Yankner, B. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36875-8 · Cited by 373
Glut‐1 deficiency syndrome: Clinical, genetic, and therapeutic aspects
Wang, D., Pascual, J. M., Yang, H., Engelstad, K., Jhung, S., Sun, R. P., & De Vivo, D. C. (2005) · Annals of Neurology · doi:10.1002/ana.20331 · Cited by 329
A ketogenic diet reduces amyloid beta 40 and 42 in a mouse model of Alzheimer's disease
Van der Auwera, I., Wera, S., Van Leuven, F., & Henderson, S. T. (2005) · Nutrition & Metabolism · doi:10.1186/1743-7075-2-28 · Cited by 307
Self-citationTreatment of Parkinson disease with diet-induced hyperketonemia: A feasibility study
VanItallie, T. B., Nonas, C., Di Rocco, A., Boyar, K., Hyams, K., & Heymsfield, S. B. (2005) · Neurology · doi:10.1212/01.wnl.0000152046.11390.45 · Cited by 300
Axonal Transport and Alzheimer's Disease
Stokin, G. B., & Goldstein, L. S. B. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.103004.142637 · Cited by 293
Calon, F., & Cole, G. (2007) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2007.10.019 · Cited by 291
A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis
Zhao, Z., Lange, D. J., Voustianiouk, A., MacGrogan, D., Ho, L., Suh, J., Humala, N., Thiyagarajan, M., Wang, J., & Pasinetti, G. M. (2006) · BMC Neuroscience · doi:10.1186/1471-2202-7-29 · Cited by 286
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.6.203 · Cited by 280
Mechanisms of mitochondrial dysfunction and energy deficiency in Alzheimer’s disease
Atamna, H., & Frey, W. H. (2007) · Mitochondrion · doi:10.1016/j.mito.2007.06.001 · Cited by 278
Velliquette, R. A., O'Connor, T., & Vassar, R. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2350-05.2005 · Cited by 254
KETY, S. S., WOODFORD, R. B., HARMEL, M. H., FREYHAN, F. A., APPEL, K. E., & SCHMIDT, C. F. (1948) · American Journal of Psychiatry · doi:10.1176/ajp.104.12.765 · Cited by 244
GLUT1 deficiency syndrome – 2007 update
Klepper, J., & Leiendecker, B. (2007) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2007.00707.x · Cited by 240
Cerebral Metabolic Adaptation and Ketone Metabolism after Brain Injury
Prins, M. L. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600543 · Cited by 229
The Ketogenic diet: from molecular mechanisms to clinical effects
(2006) · Epilepsy Research · doi:10.1016/j.eplepsyres.2005.10.003 · Cited by 213
Age-dependent reduction of cortical contusion volume by ketones after traumatic brain injury
Prins, M. L., Fujima, L. S., & Hovda, D. A. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20633 · Cited by 193
CRAFT, S., ASTHANA, S., SCHELLENBERG, G., BAKER, L., CHERRIER, M., BOYT, A. A., MARTINS, R. N., RASKIND, M., PESKIND, E., & PLYMATE, S. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06371.x · Cited by 191
Positron emission tomographic studies of aging and Alzheimer disease.
de Leon, M. J., Ferris, S. H., GEORGE, A. E., Christman, D. R., Fowler, J. S., Gentes, C., Reisberg, ., Gee, B., Emmerich, M., Yonekura, Y., et al. (1983) · PubMed Central · Cited by 187
Early detection of Alzheimer’s disease using neuroimaging
Mosconi, L., Brys, M., Glodzik-Sobanska, L., De Santi, S., Rusinek, H., & de Leon, M. J. (2007) · Experimental Gerontology · doi:10.1016/j.exger.2006.05.016 · Cited by 187
Suzuki, M., Suzuki, M., Sato, K., Dohi, S., Sato, T., Matsuura, A., & Hiraide, A. (2001) · Japanese Journal of Pharmacology · doi:10.1254/jjp.87.143 · Cited by 160
Ketone Bodies Stimulate Chaperone-mediatedAutophagy
Finn, P. F., & Dice, J. F. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502456200 · Cited by 143
Suzuki, M., Suzuki, M., Kitamura, Y., Mori, S., Sato, K., Dohi, S., Sato, T., Matsuura, A., & Hiraide, A. (2002) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.89.36 · Cited by 141
Klepper, J., Scheffer, H., Leiendecker, B., Gertsen, E., Binder, S., Leferink, M., Hertzberg, C., Näke, A., Voït, T., & Willemsen, M. A. A. P. (2005) · Neuropediatrics · doi:10.1055/s-2005-872843 · Cited by 138
Massieu, L., Haces, M. L., Montiel, T., & Hernández‐Fonseca, K. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00266-5 · Cited by 130
Acetoacetate protects neuronal cells from oxidative glutamate toxicity
Noh, H. S., Hah, Y., Nilufar, R., Han, J., Bong, J.-H., Kang, S. S., Cho, G. J., & Choi, W. S. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20736 · Cited by 127
Levin-Allerhand, J. A., Lominska, C. E., & Smith, J. D. (2002) · PubMed · Cited by 117
Prins, M. L., Lee, S. M., Fujima, L. S., & Hovda, D. A. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02542.x · Cited by 113
Noh, H. S., Kim, Y. S., Lee, H. P., Chung, K. M., Kim, D. W., Kang, S. S., Cho, G. J., & Choi, W. S. (2003) · Epilepsy Research · doi:10.1016/s0920-1211(02)00262-0 · Cited by 111
D‐β‐hydroxybutyrate protects dopaminergic SH‐SY5Y cells in a rotenone model of Parkinson's disease
Imamura, K., Takeshima, T., Kashiwaya, Y., Nakaso, K., & Nakashima, K. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.21021 · Cited by 101
Mahley, R. W., & Huang, Y. (2006) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2006.00679.x · Cited by 94
Expression, regulation, and functional role of glucose transporters (GLUTs) in brain
Dwyer, D. S., Vannucci, S. J., & Simpson, I. A. (2002) · International review of neurobiology · doi:10.1016/s0074-7742(02)51005-9 · Cited by 87
Brain metabolic decreases related to the dose of the ApoE e4 allele in Alzheimer's disease
Mosconi, L., Nacmias, B., Sorbi, S., Cristofaro, M. T. R. D., Fayazz, M., Tedde, A., Bracco, L., Herholz, K., & Pupi, A. (2004) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.014993 · Cited by 86
Expression of monocarboxylate transporter MCT1 in normal and neoplastic human CNS tissues
Froberg, M. K., Gerhart, D. Z., Enerson, B. E., Manivel, C. J., Guzman‐Paz, M., Seacotte, N., & Drewes, L. R. (2001) · Neuroreport · doi:10.1097/00001756-200103260-00030 · Cited by 85
High carbohydrate diets and Alzheimer's disease
Henderson, S. T. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2003.11.028 · Cited by 80
Self-citationD ‐β‐hydroxybutyrate is neuroprotective against hypoxia in serum‐free hippocampal primary cultures
Masuda, R., Monahan, J. W., & Kashiwaya, Y. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20464 · Cited by 79
Longitudinal SPECT study in Alzheimer's disease: relation to apolipoprotein E polymorphism
Lehtovirta, M., Kuikka, J. T., Helisalmi, S., Hartikainen, P. H., Mannermaa, A., Ryynänen, M., Riekkinen, P., & Soininen, H. S. (1998) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.64.6.742 · Cited by 68
Corder, E. H., Jelić, V., Basun, H., Lannfelt, L., Valind, S., Winblad, B. G., & Nordberg, A. K. (1997) · Archives of Neurology · doi:10.1001/archneur.1997.00550150035013 · Cited by 65
Dardzinski, B., Smith, S. L., Towfighi, J., Williams, G. D., Vannucci, R., & Smith, M. B. (2000) · Pediatric Research · doi:10.1203/00006450-200008000-00021 · Cited by 60
Mejía-Toiber, J., Montiel, T., & Massieu, L. (2006) · Neurochemical Research · doi:10.1007/s11064-006-9189-5 · Cited by 53
The effect of APOE ε4 allele on cerebral glucose metabolism in AD is a function of age at onset
Hirono, N., Hashimoto, M., Yasuda, M., Ishii, K., Sakamoto, S., Kazui, H., & Mori, E. (2002) · Neurology · doi:10.1212/wnl.58.5.743 · Cited by 42
When is a high fat diet not a high fat diet?
Feinman, R. D. (2005) · Nutrition & Metabolism · doi:10.1186/1743-7075-2-27 · Cited by 9
Cited by
Henderson, S. T., Vogel, J. L., Barr, L. J., Garvin, F., Jones, J. J., & Costantini, L. C. (2009) · Nutrition & Metabolism · doi:10.1186/1743-7075-6-31 · Cited by 548
Self-citationEffects of Ketone Bodies on Brain Metabolism and Function in Neurodegenerative Diseases
Jensen, N. J., Wodschow, H. Z., Nilsson, M., & Rungby, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228767 · Cited by 446
ESPEN guidelines on nutrition in dementia
Volkert, D., Chourdakis, M., Faxen-Irving, G., Frühwald, T., Landi, F., Suominen, M. H., Vandewoude, M., Wirth, R., & Schneider, S. M. (2015) · Clinical Nutrition · doi:10.1016/j.clnu.2015.09.004 · Cited by 442
Cunnane, S. C., Courchesne‐Loyer, A., St‐Pierre, V., Vandenberghe, C., Pierotti, T., Fortier, M., Croteau, E., & Castellano, C. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12999 · Cited by 250
Cavaleri, F., & Bashar, E. (2018) · Journal of Nutrition and Metabolism · doi:10.1155/2018/7195760 · Cited by 126
Metadata
- Authors
- Henderson, S. T.
- Venue
- Neurotherapeutics
- Publisher
- Elsevier BV
- Published
- 2008-07
- Volume
- 5
- Issue
- 3
- Pages
- 470-480
- ISSN
- 1878-7479 (ISSN-L)
- OpenAlex
- W2151715627
- Cited by
- 323
- References
- 70
- FWCI
- 4.62
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.